Printer Friendly

JONES MEDICAL ENTERS INTO AGREEMENT TO ACQUIRE BRONSON PHARMACEUTICALS

 ST. LOUIS, March 22 /PRNewswire/ -- Jones Medical Industries, Inc. (NASDAQ: JMED) today entered into an agreement to purchase all the outstanding shares of Bronson Pharmaceuticals for $10.5 million.
 Bronson Pharmaceuticals is a 33 year old privately owned company located in La Canada, Calif. with 1992 sales of Nutritional and OTC Pharmaceutical products of $15.4 million up from $13.9 million in 1991. The closing is anticipated to be on or before March 26, 1993 subject to the completion of JMED's due diligence.
 Bronson Pharmaceuticals was founded in 1960, by the late Frank Bronson, with a single product, Bronson's Prenatal, professionally marketed to OB/GYN's. Today the company has over 150 products marketed primarily by direct response marketing to over 400,000 consumers, physicians and pharmacies throughout the United States and Canada. Bronson has 60 employees including a broad based management team headed up by Michael Irwin, CEO, and Ray Hensley, president. Mr. Irwin has an extensive background in direct response marketing and Mr. Hensley has over 30 years experience in the pharmaceutical industry.
 Mr. Dennis M. Jones, JMED's chairman and CEO, in commenting on the company's second acquisition in 1993 said, "The synergies inherent with the acquisition of Bronson Pharmaceuticals are numerous. First of all, JMED's sales could exceed $40 million for 1993 and $50 million in 1994. Secondly, JMED has the capability to manufacture the majority of Bronson's products which will greatly enhance gross margins. Finally, JMED's ability to pay cash for a growing profitable company will allow the acquisition of Bronson Pharmaceuticals to be immediately additive to our bottom line."
 In February 1993, JMED announced the acquisition of the $2.4 million Derma System Product Line from Tsumura Medical and JMED's Dec. 31, 1992 year end results of $24,057,000 in sales and net income of $3,732,000 or $.40 per share.
 -0- 3/22/93
 /CONTACT: Investor Relations of Jones Medical Industries, 314-432-7557/
 (JMED)


CO: Jones Medical Industries, Inc.; Bronson Pharmaceuticals ST: Missouri IN: MTC SU: TNM

SH -- NY084 -- 8384 03/22/93 17:06 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 22, 1993
Words:343
Previous Article:THREE BOSTON MEN ARRESTED IN CELLULAR TELEPHONE CLONING CASE
Next Article:DISTINGUISHED SCHOLAR, FORMER WHITE HOUSE ECONOMIST GEORGE G. DALY NAMED DEAN OF NYU STERN SCHOOL OF BUSINESS


Related Articles
JONES MEDICAL PURCHASES 16.7 PERCENT EQUITY IN ABANA PHARMACEUTICALS
JONES MEDICAL COMPLETES ACQUISITION OF BRONSON PHARMACEUTICALS
JONES MEDICAL REPORTS UNUSUALLY LARGE APRIL 1993 THROMBINAR SALES
JONES MEDICAL REPORTS RECORD FIRST QUARTER WITH NET INCOME UP 16 PERCENT
JONES MEDICAL POST 66% NET INCOME GAIN FOR YEAR
JONES MEDICAL DISCUSSES EARLY 1994 RESULTS AT MABON CONFERENCE
JONES MEDICAL REPORTS FIRST QUARTER 1994 EARNINGS
JONES MEDICAL ANNOUNCES ESTIMATED FIRST QUARTER EARNINGS RESULTS
JONES MEDICAL ANNOUNCES SEVENTH CONSECUTIVE ANNUAL INCREASE IN ITS QUARTERLY DIVIDEND; TWENTY PERCENT DIVIDEND INCREASE TO $.03 QUARTERLY
JONES MEDICAL REPORTS ALL TIME RECORD QUARTER AND SIX MONTH EARNINGS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters